Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Thyroid Gland Carcinoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Head and Neck Cancer (561
)
Thyroid Gland Anaplastic Carcinoma (70
)
Thyroid Gland Medullary Carcinoma (61
)
Thyroid Gland Papillary Carcinoma (58
)
Thyroid Gland Follicular Carcinoma (25
)
Thyroid Gland Hurthle Cell Carcinoma (12
)
Head and Neck Cancer (561
)
Thyroid Gland Anaplastic Carcinoma (70
)
Thyroid Gland Medullary Carcinoma (61
)
Thyroid Gland Papillary Carcinoma (58
)
Thyroid Gland Follicular Carcinoma (25
)
Thyroid Gland Hurthle Cell Carcinoma (12
)
›
Associations
(359)
News
Trials
Search handles
@AaronGoodman33
@BenWestphalen
@DrEzraCohen
@DrHaddadRobert
@GRecondoMD
@GautschiOliver
@Ja_Capdevila
@NievesM42607618
@PTarantinoMD
@RenoHemonc
@RielyMD
@StephenVLiu
@VivekSubbiah
@davidhenrymd
@dawood_findakly
@drenriquegrande
@jamecancerdoc
@marklewismd
@mihaela_aldea
@montypal
@n8pennell
@pashtoonkasi
@rbryanbell
@schoffski
@sejadiMD
@weoncologists
Search handles
@AaronGoodman33
@BenWestphalen
@DrEzraCohen
@DrHaddadRobert
@GRecondoMD
@GautschiOliver
@Ja_Capdevila
@NievesM42607618
@PTarantinoMD
@RenoHemonc
@RielyMD
@StephenVLiu
@VivekSubbiah
@davidhenrymd
@dawood_findakly
@drenriquegrande
@jamecancerdoc
@marklewismd
@mihaela_aldea
@montypal
@n8pennell
@pashtoonkasi
@rbryanbell
@schoffski
@sejadiMD
@weoncologists
Filter by
Latest
9ms
📢 #Thyroid Specialists! 📚 Join us this Friday for the TIRO x MDs Journal Club session featuring @naifa_busaidy as our guest speaker! 🎙️👩🔬 She'll be sharing her insights on the use of systemic therapies in BRAF V600E mutated radioactive iodine refractory Thyroid Cancer. 🦋🩺 (@camilo_gzzv)
9 months ago
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
9ms
Report @Annals_Oncology on weight gain with #RET inhibitors selpercatinib and pralsetinib from Drs. @mgoudaMD @VivekSubbiah. 73% had weight gain. Of those, 41% G1, 31% G2, 28% G3. More common in thyroid cancer and TKI experienced. No OS/PFS difference. https://t.co/IvCwsMJxV7 (@StephenVLiu)
9 months ago
Retevmo (selpercatinib) • Gavreto (pralsetinib)
9ms
I travel to MDA from Louisville, KY several times a year for medullary thyroid cancer monitoring and lung & breast cancer follow up. MDA is the most amazing place. I couldn’t ask for a better patient experience. Job well done, Dr. Frumovitz. Sending positive vibes your way. (@gerber2012)
9 months ago
Clinical
9ms
@EllieMaghamiMD presenting on #thyroidcancer at #AHNS2023 International Conference in Montreal! @AHNSinfo (@AHNSEndo)
9 months ago
9ms
Dr. Tsung-Lin Yang and Dr. Allen Ho at the 2023 AHNS International Conference on Head and Neck Cancer! @allenhomd @AHNSinfo #thyroidcancer #AHNS2023 (@AHNSEndo)
9 months ago
9ms
Congratulations to our newly graduated fellow Dr. Albert Han on winning 🥇 prize at the @ahnsinfo poster competition examining expression differences in dedifferentiated BRAF-mutated papillary #thyroidcancer Awesome work! @MDAndersonNews (@JenniferWangMD)
9 months ago
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
Fantastic learning programme from @DrEzraCohen ! Updates on #NTRK fusions in #thyroidcancer with a focus on: ✅Treatments such as #entrectinib and #larotrectinib ✅ Histopathology ✅Efficacy and safety of treatment Watch and download the slides here👇 https://t.co/KEY6lBsvUT (@PresOnc_Connect)
9 months ago
Clinical
|
NTRK (Neurotrophic receptor tyrosine kinase)
|
NTRK fusion
|
Vitrakvi (larotrectinib) • Rozlytrek (entrectinib)
9ms
Today, @rhbelcher & @GelbardMd shared their expertise at #AHNS2023. Dr. Belcher presented "Preoperative Considerations in Management of Pediatric Thyroid Cancer" & Dr. Gelbard presented "Tracheal Resection & Reconstruction". @AHNSinfo #ENT #OHNS #MedEd (@VanderbiltENT)
9 months ago
Clinical
10ms
A throwback Thursday 2020 conference video. Topic: Thyroid surgery, presented by surgeon Dr. Allen Ho, M.D. @allenhomd. See more like this at Conference, Oct 13-15, 2023 in Denver or Virtually. Register free at https://t.co/jr2Ferww0w View at: https://t.co/S6uVZOITAZ #ThyCa20 (@ThyCaInc)
10 months ago
Video • Surgery
10ms
I had papillary thyroid carcinoma stage one..confined to thyroid wid no margins extending beyond thyroid..still this is third year and I am undergoing RAI whole body scan after alleviating tsh and then take RAI- 5MC, then scan. How long I would be on cancer radar (@palwaschaarbab)
10 months ago
10ms
Thanks to @MichaelOrestes, @msebe, @allenhomd, @ZandifarMD, and Andrew Orosco MD for a terrific #AHNSChat webinar with @ThyCaInc on #thyroid scars. See you next round! #thyroidcancer#thyroidcancer #thyroidcancer You can watch the recording here: https://t.co/SkdokpJ2rK (@AHNSEndo)
10 months ago
10ms
https://t.co/XUT5pFjUXo Hot off the press. Check out our @JAMAOto paper to learn more about the next frontier in the thyroid cancer molecular testing domain @michaelyehmd @MashaLivhitsMD @JamesWuMD @MelissaGLechner @diptisajed @UCLASurgeryRes @UCLASurgery @UCLAPath @UCLAHealth (@MSchumm90)
10 months ago
Surgery
10ms
Oncology master level board review! What do the following malignancies all have in common? @Dr_R_Kurzrock Mandibular ameloblastoma Hairy cell leukemia Melanoma Erdheim Chester disease Papillary thyroid cancer (@AaronGoodman33)
10 months ago
Review
10ms
BRAF mutation Seen in melanoma (40-60%) papillary thyroid carcinoma (45%), colonic adenocarcinoma (10-15%), hairy cell leukemia (~100%) lung adenocarcinoma, epithelioid glioblastoma, and hematologic malignancies, including hairy cell leukemia, LCH, ECD (@Sthanu5)
10 months ago
BRAF (B-raf proto-oncogene)
|
BRAF mutation
10ms
We provided these fab units for the paediatric rooms at UCLH for patients having thyroid cancer treatment @MarkGaze 🦋 (@ButterflyThyro)
10 months ago
Clinical
10ms
Our darling daughter had breast cancer at 27yo, double mastectomy and chemo. No HRT. 10 years later she has been diagnosed with thyroid cancer. Half thyroid removed and radiation therapy. Also has had pre cancerous polyps removed. (@Judyw561)
10 months ago
10ms
I'm grateful to #IFHNOS23 for inviting me to talk on #thyroidcancer. Appreciated many meetings and enjoyed each moment w/@laura_locati @arianna_ottini @LuanaGSousaMD +Renata Ferrarotto +Irene Braña, all bold women committed to improving research&care of patients w/#headneckcancer (@elenacolomboMD)
10 months ago
Clinical
10ms
@novonordisk stock falls on Ozempic 'safety signal' to Thyroid cancer https://t.co/CYuQXcS679 via @YahooFinance @PharmRJ (@pash22)
10 months ago
Clinical
10ms
@ThyroidCongress ECO also participated in #WCTC2023. Thanks for coming to us. See you in Boston in 2023!😁😁 (@MicrowaveEco)
10 months ago
10ms
Thank you @DrGregFarwell for the inspiring lecture on personalized head and neck #cancercare! @Thyroid_Surgeon @Penn_ENT (@PSH_OTO)
10 months ago
10ms
This session is on right now! Join Dr.@GillSharlene, Dr. Kassam, Dr. Chau and Dr. Sheffield as they discuss facilitating access to precision therapies for Colorectal, Lung and Thyroid Cancers. Join here: https://t.co/dlTd6rCZcF (@ccranorg)
10 months ago
10ms
Great job @lucyweigall and Sasha 👏👏 Thanks to @ThyroidCongress and @BAETS_UK a great event! #WCTC2023 #thyroidcancer #hypoparathyroidism (@ParathyroidUK)
10 months ago
10ms
#relaxin #thyroidcancer #ENDO2023 @DrAKotwal Congratulations amazing 👏🙏👏 (@AskDrShashank)
10 months ago
10ms
Such a fun experience presenting my team’s work on #relaxin being a novel #marker for #thyroidcancer #ENDO2023 @UnmcDem @UNMC_IM @DeptVetAffairs @AFMResearch @unmc_research @UNMC_PathMicro @ana_yuil @whitsgoldner @DrFingeret (@DrAKotwal)
10 months ago
10ms
A recent @thyroidjournal study by @RandolphGreg and colleagues looks at the existing inequities in the management of #thyroid cancer. @DrAKotwal @ASCO @ThyCaInc @thancfoundation https://t.co/uoLfKK3eTY #medtwitter #endotwitter #onctwitter (@clinicalthyroid)
10 months ago
10ms
Day 3 with Kyung Tae, @jonrussellmd , Dave Terris, and Leo Rangel at WCTC2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
See you in Boston in 2025! #WCTC2023 #thyroidcancer @RandolphGreg (@ThyroidCongress)
10 months ago
10ms
Michael Freeman, @allenhomd, and Jyortimoy Phookan MD after the video session at #wctc2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
Video
10ms
Day 3 with the Scottish ENT contingent at #wctc2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
Day 3 featuring the DEI panel at #wctc2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
Megan Haymart, MD showing the high variation in follow-up after low risk thyroid cancer. Looking forward to updates in ATA guidelines addressing de-escalation of care for these patients. @UMIntMed @UM_IHPI @UMEndoFellows @MariaPapaleont1 (@KMizokamiStout)
10 months ago
Clinical
10ms
@MarkZafereoMD and Vicki Banuchi MD and others at Oxo reception at #wctc2023 in London. (@ThyroidCongress)
10 months ago
10ms
The Forum was coordinated by Dr. Fabian Pitoia, Dr. Ana Luiza Maia, and Dr. Luiz P. Kowalski. #lats #thyroid #wctc2023 #ForumLATS (@LATS_Society)
10 months ago
10ms
@D_Shonka and Babak Givi MD at the #wctc23 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
Amazing discussions this morning on #advanced #thyroidcancer with great colleagues as co-panelists! #WCTC2023 @MarkZafereoMD @MDAndersonNews @MoffittNews @ThyroidCongress (@AgostoSarimar)
10 months ago
Metastases
10ms
@DrMCabanillas presenting on anaplastic thyroid cancer at #WCTC2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
@allenhomd and @MS_Endosurgeon at #WCTC2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
Kate Newbold, @DrMCabanillas, and Ashok Shaha speaking at the anaplastic thyroid cancer panel at #WCTC2023 in London. #thyroidcancer #anaplastic (@ThyroidCongress)
10 months ago
10ms
Ashok Shaha leading the anaplastic thyroid cancer panel including @DrMCabanillas, Peter Sadow, and others at #WCTC2023 in London. #thyroidcancer #anaplastic (@ThyroidCongress)
10 months ago
10ms
Day 2 of #wctc2023 in London, with @D_Shonka! #thyroidcancer (@ThyroidCongress)
10 months ago
10ms
@LouiseDaviesMD, Akira Miyauchi, Mike Tuttle, and others at the low risk #thyroidcancer panel at #WCTC2023 in London. (@ThyroidCongress)
10 months ago
10ms
@RandolphGreg discussing neoadjuvant systemic therapy at #WCTC2023 in London. #thyroidcancer (@ThyroidCongress)
10 months ago
Clinical
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login